-
1
-
-
84891646690
-
Adherence to CONSORT adverse event reporting guidelines in randomized clinical trials evaluating systemic cancer therapy: a systematic review
-
Peron J, Maillet D, Gan HK, Chen EX, You B Adherence to CONSORT adverse event reporting guidelines in randomized clinical trials evaluating systemic cancer therapy: a systematic review. J Clin Oncol 2013, 31:3957-3963.
-
(2013)
J Clin Oncol
, vol.31
, pp. 3957-3963
-
-
Peron, J.1
Maillet, D.2
Gan, H.K.3
Chen, E.X.4
You, B.5
-
2
-
-
84894864108
-
Adverse event reporting in cancer clinical trial publications
-
Sivendran S, Latif A, McBride RB, et al. Adverse event reporting in cancer clinical trial publications. J Clin Oncol 2014, 32:83-89.
-
(2014)
J Clin Oncol
, vol.32
, pp. 83-89
-
-
Sivendran, S.1
Latif, A.2
McBride, R.B.3
-
3
-
-
0036513556
-
Assessment of toxicity in cooperative oncology clinical trials: the long and short of it
-
Gwede CK, Johnson DJ, Daniels SS, Trotti A Assessment of toxicity in cooperative oncology clinical trials: the long and short of it. J Oncol Manag 2002, 11:15-21.
-
(2002)
J Oncol Manag
, vol.11
, pp. 15-21
-
-
Gwede, C.K.1
Johnson, D.J.2
Daniels, S.S.3
Trotti, A.4
-
4
-
-
8744229000
-
Better reporting of groups in randomized trials: an extension of the CONSORT statement
-
Ioannidis JP, Evans SJ, Gotzsche PC, et al. Better reporting of groups in randomized trials: an extension of the CONSORT statement. Ann Intern Med 2004, 141:781-788.
-
(2004)
Ann Intern Med
, vol.141
, pp. 781-788
-
-
Ioannidis, J.P.1
Evans, S.J.2
Gotzsche, P.C.3
-
6
-
-
84944674953
-
The imperative for a new approach to toxicity analysis in oncology clinical trials
-
published online Aug 1.
-
Thanarajasingam G, Hubbard JM, Sloan JA, Grothey A The imperative for a new approach to toxicity analysis in oncology clinical trials. J Natl Cancer Inst 2015, published online Aug 1. 10.1093/jnci/djv216.
-
(2015)
J Natl Cancer Inst
-
-
Thanarajasingam, G.1
Hubbard, J.M.2
Sloan, J.A.3
Grothey, A.4
-
7
-
-
34347218947
-
TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group
-
Trotti A, Pajak TF, Gwede CK, et al. TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. Lancet Oncol 2007, 8:613-624.
-
(2007)
Lancet Oncol
, vol.8
, pp. 613-624
-
-
Trotti, A.1
Pajak, T.F.2
Gwede, C.K.3
-
8
-
-
84911369119
-
-
CRC Press, Taylor & Francis Group, LLC, Boca Raton, FL, USA
-
Der G, Everitt BS Applied Medical Statistics Using SAS 2012, CRC Press, Taylor & Francis Group, LLC, Boca Raton, FL, USA.
-
(2012)
Applied Medical Statistics Using SAS
-
-
Der, G.1
Everitt, B.S.2
-
9
-
-
25644445526
-
-
John Wiley & Sons, Hoboken, NJ
-
Fitzmaurice GM, Laird NM, Ware JH Applied longitudinal analysis 2011, John Wiley & Sons, Hoboken, NJ. 2nd edn.
-
(2011)
Applied longitudinal analysis
-
-
Fitzmaurice, G.M.1
Laird, N.M.2
Ware, J.H.3
-
10
-
-
0142184291
-
What happened to all the patients? Event charts for summarizing individual patient data and displaying clinically significant changes in quality of life data
-
Atherton PJ, Jasperson B, Nibbe A, et al. What happened to all the patients? Event charts for summarizing individual patient data and displaying clinically significant changes in quality of life data. Drug Info J 2003, 37:11-21.
-
(2003)
Drug Info J
, vol.37
, pp. 11-21
-
-
Atherton, P.J.1
Jasperson, B.2
Nibbe, A.3
-
11
-
-
40749105725
-
Graphical approaches to the analysis of safety data from clinical trials
-
Amit O, Heiberger RM, Lane PW Graphical approaches to the analysis of safety data from clinical trials. Pharm Stat 2008, 7:20-35.
-
(2008)
Pharm Stat
, vol.7
, pp. 20-35
-
-
Amit, O.1
Heiberger, R.M.2
Lane, P.W.3
-
13
-
-
1842569206
-
A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
-
Goldberg RM, Sargent DJ, Morton RF, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004, 22:23-30.
-
(2004)
J Clin Oncol
, vol.22
, pp. 23-30
-
-
Goldberg, R.M.1
Sargent, D.J.2
Morton, R.F.3
-
14
-
-
0034676813
-
Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial
-
Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 2000, 356:2059-2063.
-
(2000)
Lancet
, vol.356
, pp. 2059-2063
-
-
Loprinzi, C.L.1
Kugler, J.W.2
Sloan, J.A.3
-
15
-
-
33751103252
-
Applying QOL assessments: solutions for oncology clinical practice and research, part 1
-
Sloan JA, Dueck AC, Frost MH, et al. Applying QOL assessments: solutions for oncology clinical practice and research, part 1. Curr Prob Cancer 2005, 29:265-352.
-
(2005)
Curr Prob Cancer
, vol.29
, pp. 265-352
-
-
Sloan, J.A.1
Dueck, A.C.2
Frost, M.H.3
-
16
-
-
36048972049
-
Applying QOL assessments: solutions for oncology clinical practice and research, part 2
-
Sloan JA, Dueck AC, Frost MH, et al. Applying QOL assessments: solutions for oncology clinical practice and research, part 2. Curr Prob Cancer 2006, 30:233-332.
-
(2006)
Curr Prob Cancer
, vol.30
, pp. 233-332
-
-
Sloan, J.A.1
Dueck, A.C.2
Frost, M.H.3
-
17
-
-
84964601958
-
-
SAS Global Forum. April 22-25, 2012. Orlando, FL, USA.
-
Novotny PJ, Tan AD, Foster NR, Sloan JA. SAS tools for cost effective and high quality clinical trial reporting. SAS Global Forum. April 22-25, 2012. Orlando, FL, USA.
-
SAS tools for cost effective and high quality clinical trial reporting
-
-
Novotny, P.J.1
Tan, A.D.2
Foster, N.R.3
Sloan, J.A.4
-
18
-
-
33748446657
-
Adverse event reporting in publications compared with sponsor database for cancer clinical trials
-
Scharf O, Colevas AD Adverse event reporting in publications compared with sponsor database for cancer clinical trials. J Clin Oncol 2006, 24:3933-3938.
-
(2006)
J Clin Oncol
, vol.24
, pp. 3933-3938
-
-
Scharf, O.1
Colevas, A.D.2
-
19
-
-
84870720349
-
Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology
-
Basch E, Abernethy AP, Mullins CD, et al. Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. J Clin Oncol 2012, 30:4249-4255.
-
(2012)
J Clin Oncol
, vol.30
, pp. 4249-4255
-
-
Basch, E.1
Abernethy, A.P.2
Mullins, C.D.3
-
20
-
-
80051715635
-
Electronic toxicity monitoring and patient-reported outcomes
-
Basch EM, Reeve BB, Mitchell SA, et al. Electronic toxicity monitoring and patient-reported outcomes. Cancer J 2011, 17:231-234.
-
(2011)
Cancer J
, vol.17
, pp. 231-234
-
-
Basch, E.M.1
Reeve, B.B.2
Mitchell, S.A.3
-
21
-
-
84921904953
-
Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials
-
Di Maio M, Gallo C, Leighl NB, et al. Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials. J Clin Oncol 2015, 33:910-915.
-
(2015)
J Clin Oncol
, vol.33
, pp. 910-915
-
-
Di Maio, M.1
Gallo, C.2
Leighl, N.B.3
-
22
-
-
84883855864
-
Feasibility of long-term patient self-reporting of toxicities from home via the internet during routine chemotherapy
-
Judson TJ, Bennett AV, Rogak LJ, et al. Feasibility of long-term patient self-reporting of toxicities from home via the internet during routine chemotherapy. J Clin Oncol 2013, 31:2580-2585.
-
(2013)
J Clin Oncol
, vol.31
, pp. 2580-2585
-
-
Judson, T.J.1
Bennett, A.V.2
Rogak, L.J.3
-
23
-
-
36849028533
-
Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy
-
Basch E, Iasonos A, Barz A, et al. Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. J Clin Oncol 2007, 25:5374-5380.
-
(2007)
J Clin Oncol
, vol.25
, pp. 5374-5380
-
-
Basch, E.1
Iasonos, A.2
Barz, A.3
-
24
-
-
84880656074
-
Harnessing technology to improve clinical trials: study of real-time informatics to collect data, toxicities, image response assessments, and patient-reported outcomes in a phase II clinical trial
-
Pietanza MC, Basch EM, Lash A, et al. Harnessing technology to improve clinical trials: study of real-time informatics to collect data, toxicities, image response assessments, and patient-reported outcomes in a phase II clinical trial. J Clin Oncol 2013, 31:2004-2009.
-
(2013)
J Clin Oncol
, vol.31
, pp. 2004-2009
-
-
Pietanza, M.C.1
Basch, E.M.2
Lash, A.3
|